Prognostic factors in Barrett's esophagus: an immunohistochemical and morphometric study of 120 cases

Citation
C. Illueca et al., Prognostic factors in Barrett's esophagus: an immunohistochemical and morphometric study of 120 cases, REV ESP E D, 92(11), 2000, pp. 732-737
Citations number
44
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
ISSN journal
11300108 → ACNP
Volume
92
Issue
11
Year of publication
2000
Pages
732 - 737
Database
ISI
SICI code
1130-0108(200011)92:11<732:PFIBEA>2.0.ZU;2-Z
Abstract
Barrett's esophagus is a condition in which the squamous mucosa that normal ly lines the distal esophagus is replaced by a columnar type of epithelium. Although it carries a clear risk of adenocarcinoma, the estimation of this risk and therefore the value of endoscopic screening remain highly controv ersial. AIM: to investigate more sensitive techniques to identify those patients wh o are at high risk of developing cancer and who need intensive endoscopic s urveillance for early detection. METHODS: a morphologic, histochemical and morphometric study was performed on paraffin-embedded material from 120 patients with Barrett's esophagus an d 18 with adenocarcinoma. In addition, each sample was analyzed immunohisto chemically with proliferating cell nuclear antigen (PCNA), p53, c-erbB-2, C EA and EMA antibodies. RESULTS: in all zones of the glandular mucosa we found a higher percentage of PCNA-positive nuclei when the specialized epithelium was present. We saw PCNA expression in 75% of the patients with adenocarcinoma, and p53 expres sion in 15% of the patients without dysplasia, 37% of the patients with dys plasia and 44% of the patients with adenocarcinoma. Positivity for c-erbB-2 was found in 38% of the patients without dysplasia, 53% of those with dysp lasia and 37% of those with adenocarcinoma. Aneuploidy was found in 70% of the patients with metaplasia or dysplasia and in all patients with adenocar cinoma. CONCLUSIONS: we conclude that p53, PCNA overexpression and aneuploidy are m arkers of risk for malignancy in Barrett's esophagus.